EC Pulmonology and Respiratory Medicine

Sarcoidosis, an enigmatic multisystem granulomatous disorder, has forever posed unique diagnostic challenges for clinicians in daily practice. It is identified by the presence of non-caseating granulomas in affected organs, most commonly the lungs. Diagnosis is never secure and usually done when the probability likelihood alternative diseases is extremely low by a detailed differential diagnostic assessment [1-4]. Yet, its diagnosis often requires traversing a labyrinthine process, especially when the manifestations are atypical, isolated single organ involvement at the initial setting, and patients with stage 0 disease.

Keywords: Sarcoidosis; Kveim Test; Diagnosis

1. Baughman RP., et al. “A Concise Review of Pulmonary Sarcoidosis”. American Journal of Respiratory and Critical Care Medicine 5 (2011): 573-581.
2. GW Hunninghake., et al. “ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders”. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 2 (1999): 149-173.
3. Judson MA., et al. “The diagnostic pathway to sarcoidosis”. Chest2 (2003): 406-412.
4. Valeyre D., et al. “Sarcoidosis”. Lancet9923 (2014): 1155-1167.
5. Berman JS and Govender P. “The Diagnosis of Sarcoidosis”. Clinics in Chest Medicine4 (2015): 585-602.
6. Judson MA., et al. “The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool”. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 1 (2014): 19-27.
7. Tetikkurt C., et al. “Simultaneous use of FDG-18 and 68Ga-citrate PET/CT for the differential diagnosis of sarcoidosis and malignant disease”. Monaldi Archives for Chest Disease 3 (2020).